Design, Funding, and Registration
This phase 2 double-blind placebo-controlled stratified randomized clinical trial was approved by the Duke University Health System Institutional Review Board, and all participants provided written informed consent prior to enrollment. The trial was designed to compare biochemically verified 12-week smoking abstinence in daily smokers randomized to adaptive or standard pharmacotherapy in a clinical practice setting. The trial protocol and statistical plan are provided in 